DOI: 10.1002/chem.201001524
A General Palladium-Catalyzed Sonogashira Coupling of Aryl and
Heteroaryl Tosylates
Omar Rꢀkyek, Nis Halland, Andreas Lindenschmidt,* Jorge Alonso, Peter Lindemann,
Matthias Urmann, and Marc Nazarꢁ*[a]
Aryl alkynes are important synthetic precursors for a
wide variety of target compounds.[1] The most straightfor-
ward and reliable method for the regioselective construction
of these intermediates is the palladium-catalyzed Sonoga-
shira coupling.[2] Considerable efforts have been made to en-
hance the efficiency and generality of this reaction. Several
palladium catalyst systems have been developed that enable
the reaction to proceed at room temperature,[3] without re-
quiring copper(I) as a cocatalyst,[4] and expanding the sub-
strate range to aryl triflates and aryl chlorides.[5] However,
the course of the reaction, presumably due to the competing
oligomerization of the alkyne at higher concentration. Thus,
slow addition of the alkyne substrate over 8 h and high
purity of the tosylate were prerequisites for a successful
transformation. To the best of our knowledge, no general
procedure for the Sonogashira coupling of nonactivated or
ortho-substituted aryl tosylates or heteroaryl tosylates has
been reported so far. Herein, we report a general, efficient,
and robust catalyst system for the Sonogashira coupling of
diverse aryl and heteroaryl tosylates.[10]
À
the use of tosylates as coupling partners for the Csp2 Csp
We initiated our investigation by searching for conditions
under which the coupling reaction of ortho-(acetamido-
phenyl) tosylate and alkyl alkynes proceeded efficiently.
This was attractive because it gives access to the extremely
useful alkyne precursors of the Larock indole synthesis,[11]
yet the substrate is also a challenging one because there it
contains a potentially interfering acetamido group in close
proximity to the reacting tosylate moiety.[12]
bond formation has remained almost unexplored until re-
cently.[6] The use of aryl tosylates as electrophiles is attrac-
tive, since they can be prepared from the large number of
readily available phenols with less expensive reagents than
the corresponding triflates. Furthermore, aryl tosylates are
more convenient to use because they are highly crystalline
solids with a significantly higher hydrolytic stability than tri-
flates.[7] These properties allow aryl tosylates to be used as
inert protecting groups during a multistep synthesis, permit-
ting several orthogonal transformations and then their trans-
formation through Sonogashira coupling at an appropriate
stage in the synthetic sequence.[8] Conversely, the greater
stability of aryl tosylates makes this functionality less reac-
tive towards palladium-catalyzed processes. Recently, the
Sonogashira coupling of strongly activated, electron-defi-
cient para- and meta-substituted aryl tosylates was reported
using the monodentate X-Phos (2-dicyclohexylphosphino-
2’,4’,6’-triisopropylbiphenyl) ligand.[9] This catalyst system
was only successful when the alkyne was added slowly over
A screening of phosphine ligands, including PACHTUNGTRENNUNG(tBu)3,
P(Cy)3, and X-Phos, revealed that 1-dicyclohexylphosphino-
2-(di-tert-butylphosphinoethyl)ferrocene (CyPF-tBu)[13] in
combination with PdACHTUNRGTNE(UNG TFA)2 and K3PO4 effectively catalyzed
this reaction in tBuOH at 858C
to form alkyne 3 (Table 1, en-
tries 1 and 2; see also Table S-1
in the Supporting Information).
Furthermore, it was also
found that neither slow addition nor a significant excess of
alkyne was required to obtain selective and almost quantita-
tive conversion.
The optimized reaction conditions accept a broad sub-
strate scope in both aryl tosylate and alkyne coupling part-
ners (Table 1).[14] Several diversely and, in particular, ortho-
substituted aryl tosylates (Table 1, entries 7 and 8) are toler-
ated and react with comparable efficiency. Importantly, non-
activated substrates, such as phenyl tosylate, or even deacti-
vated aryl tosylates, such as para-tolyl- or ortho-methoxy-
phenyl tosylates, were found to be reactive under these con-
ditions (Table 1, entries 9–12).
[a] Dr. O. Rꢀkyek, Dr. N. Halland, Dr. A. Lindenschmidt, Dr. J. Alonso,
P. Lindemann, Dr. M. Urmann, Dr. M. Nazarꢁ
Sanofi-Aventis Deutschland GmbH, Industriepark Hçchst
Building G878, 65926 Frankfurt am Main (Germany)
Fax : (+49)69-331-399
Supporting information for this article is available on the WWW
9986
ꢂ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 9986 – 9989